Dopamine D1 receptor agonists and dopamine reuptake blockers: New treatment stratagems for Parkinson's disease

Expert Opinion on Therapeutic Patents

Volumn 6, Issue 10, 1996, Pages 949-953

  Pearce, R K B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4,5,5A,6,7,11B HEXAHYDRO 9,10 DIHYDROXY 2 PROPYL 3 THIA 5 AZACYCLOPENT 1 ENA[C]PHENANTHRENE; 4,6,6A,7,8,12B HEXAHYDRO 7 METHYLINDOLO[4,3 AB]PHENANTHRIDINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; AMFEBUTAMONE; ANTIPARKINSON AGENT; BENZATROPINE; BENZAZEPINE DERIVATIVE; BRASOFENSINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; LEVODOPA; MAZINDOL; OXIDOPAMINE; SKF 80723; SKF 83565; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL MODEL; DRUG SELECTIVITY; DYSKINESIA; HUMAN; MONKEY; MOTOR SYSTEM; NONHUMAN; PARKINSON DISEASE; REVIEW;

EID: 0029813230     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.6.10.949     Document Type: Review

References (0)